LY117018, A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM) IN THE OVARIECTOMIZED RAT

被引：0
作者：
BRYANT, HU [1 ]
MAGEE, DE [1 ]
COLE, HW [1 ]
ROWLEY, ER [1 ]
WILSON, PK [1 ]
ADRIAN, MD [1 ]
CULLINAN, GJ [1 ]
YANG, NN [1 ]
GLASEBROOK, AL [1 ]
SATO, M [1 ]
机构：
[1] ELI LILLY & CO,LILLY RES LAB,INDIANAPOLIS,IN 46285
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [21] Selective estrogen receptor modulator (SERM) drugs for the prevention of osteoporosis
    Avioli, LV
    WOMEN'S HEALTH AND MENOPAUSE: RISK REDUCTION STRATEGIES - IMPROVED QUALITY OF HEALTH, 1999, 13 : 199 - 201
  • [22] Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts
    Schafer, JM
    Lee, ES
    Dardes, RC
    Bentrem, D
    O'Regan, RM
    Reyes, AD
    Jordan, VC
    CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2505 - 2512
  • [23] Does the addition of raloxifene analogue (LY117018) allow for reduced PTH dosing during reversal of osteopenia in the ovariectomized rat?
    Watson, P
    Drost, D
    Thornton, M
    Holdsworth, D
    Fraher, L
    Hodsman, A
    Hock, J
    Bryant, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F489 - F489
  • [24] Another Selective Estrogen-Receptor Modulator for Osteoporosis
    Becker, Carolyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) : 752 - 754
  • [25] A conformationally restricted analog of raloxifene, LY357489, is a highly potent selective estrogen receptor modulator (SERM).
    Grese, TA
    Adrian, MD
    Bryant, HU
    Cole, HW
    Glasebrook, AL
    Magee, DE
    Pell, TR
    Philips, DL
    Rowley, ER
    Sato, M
    Shetler, PK
    Short, LL
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S426 - S426
  • [26] UTERINE BIOASSAY OF TAMOXIFEN, TRIOXIFENE AND A NEW ESTROGEN ANTAGONIST (LY117018) IN RATS AND MICE
    BLACK, LJ
    GOODE, RL
    LIFE SCIENCES, 1980, 26 (17) : 1453 - 1458
  • [27] Chemoprevention of colon cancer by raloxifene, a selective estrogen receptor modulator (SERM).
    Rao, Chinthalapally V.
    Janakiram, Naveena B.
    Swamy, Malisetty V.
    Guruswamy, Suresh
    Patlolla, Jagan M. R.
    Thungathurthi, Ruchita
    Kopelovich, Levy
    Steele, Vernon E.
    CANCER RESEARCH, 2006, 66 (08)
  • [28] Effects of the raloxifene analog LY117018 on B-lymphopoiesis and bone loss induced by estrogen deficiency
    Onoe, Y
    Miyaura, C
    Ohta, H
    Nozawa, S
    Suda, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : P263 - P263
  • [29] A SERM (Selective Estrogen Receptor Modulator) Treatment Based Approach to Menopause
    Foreman, Heather D.
    Thacker, Holly
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1383 - 1383
  • [30] Comparison of ERA-923, a new selective estrogen receptor modulator (SERM) for the treatment of estrogen-receptor positive breast cancer, with other SERMs.
    Greenberger, LM
    Komm, B
    Miller, C
    Annable, T
    Lyttle, R
    Frost, P
    CLINICAL CANCER RESEARCH, 2000, 6 : 4565S - 4565S
12345